Back to IONS Stock Lookup

Ionis Pharmaceuticals (IONS) –

Sep 15, 2021 07:31 AM Biogen (BIIB) to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen in Patients Previously Treated with Evrysdi
Sep 15, 2021 07:30 AM Biogen Plans to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen in Patients Previously Treated with Evrysdi® (risdiplam)
Sep 15, 2021 07:30 AM Biogen Plans to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen in Patients Previously Treated with Evrysdi® (risdiplam)
Sep 3, 2021 07:05 AM Ionis to host ATTR symposium highlighting CARDIO-TTRansform Study at 3rd European ATTR Amyloidosis meeting
Sep 2, 2021 07:26 PM Form 4 IONIS PHARMACEUTICALS For: Aug 31 Filed by: Geary Richard S
Sep 2, 2021 07:21 PM Form 4 IONIS PHARMACEUTICALS For: Aug 31 Filed by: O'NEIL PATRICK R.
Sep 2, 2021 07:21 PM Form 4 IONIS PHARMACEUTICALS For: Aug 31 Filed by: Cadoret-Manier Onaiza
Sep 2, 2021 07:21 PM Form 4 IONIS PHARMACEUTICALS For: Aug 31 Filed by: Monia Brett P
Sep 2, 2021 07:21 PM Form 4 IONIS PHARMACEUTICALS For: Aug 31 Filed by: HOUGEN ELIZABETH L
Sep 2, 2021 07:20 PM Form 4 IONIS PHARMACEUTICALS For: Aug 31 Filed by: BENNETT C FRANK
Sep 2, 2021 07:05 AM Ionis to present at upcoming virtual investor conferences
Aug 5, 2021 05:00 PM Form S-8 IONIS PHARMACEUTICALS
Aug 5, 2021 04:09 AM Ionis Pharmaceuticals (IONS) PT Lowered to $38 at Barclays
Aug 4, 2021 04:09 PM Ionis Pharmaceuticals (IONS) PT Lowered to $42 at Stifel, Following Earnings
Aug 4, 2021 03:21 PM Form 10-Q IONIS PHARMACEUTICALS For: Jun 30
Aug 4, 2021 11:16 AM Form 8-K IONIS PHARMACEUTICALS For: Aug 04
Aug 4, 2021 07:12 AM Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 1c
Aug 4, 2021 07:00 AM Ionis reports second quarter 2021 financial results and recent business achievements
Aug 2, 2021 09:30 AM Lp(a) HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events
Jul 29, 2021 07:05 AM Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen
Jul 26, 2021 04:36 PM Biogen (BIIB), Ionis (IONS) report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
Jul 26, 2021 04:35 PM Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC
Jul 21, 2021 07:05 AM Ionis to hold second quarter 2021 financial results webcast
Jul 19, 2021 08:17 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: WENDER JOSEPH H
Jul 19, 2021 08:17 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: PARSHALL B LYNNE
Jul 19, 2021 08:17 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: Reikes Peter N
Jul 19, 2021 08:16 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: MUTO FREDERICK T
Jul 19, 2021 08:15 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: LOSCALZO JOSEPH
Jul 19, 2021 08:14 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: HERMAN JOAN E
Jul 19, 2021 08:14 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: KLEIN JOSEPH III
Jul 19, 2021 08:14 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: Hayden Michael R
Jul 19, 2021 08:13 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: Diaz Allene M.
Jul 19, 2021 08:13 PM Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: BERTHELSEN SPENCER R
Jul 16, 2021 04:06 AM Ionis Pharmaceuticals (IONS) PT Lowered to $33 at Morgan Stanley
Jul 13, 2021 06:59 AM Ionis Pharmaceuticals (IONS) enters pact with Bicycle Therapeutics (BCYC) aimed at further advancing LICA technology
Jul 13, 2021 06:59 AM Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology
Jul 6, 2021 05:53 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: WENDER JOSEPH H
Jul 6, 2021 05:53 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: Reikes Peter N
Jul 6, 2021 05:52 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: PARSHALL B LYNNE
Jul 6, 2021 05:52 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: MUTO FREDERICK T
Jul 6, 2021 05:52 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: KLEIN JOSEPH III
Jul 6, 2021 05:52 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: LOSCALZO JOSEPH
Jul 6, 2021 05:52 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: Diaz Allene M.
Jul 6, 2021 05:51 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: Hayden Michael R
Jul 6, 2021 05:51 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: HERMAN JOAN E
Jul 6, 2021 05:51 PM Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: BERTHELSEN SPENCER R
Jun 25, 2021 05:20 PM Form 4 IONIS PHARMACEUTICALS For: Jun 23 Filed by: BERTHELSEN SPENCER R
Jun 17, 2021 05:05 PM Form 4 IONIS PHARMACEUTICALS For: Jun 15 Filed by: MUTO FREDERICK T
Jun 14, 2021 06:46 PM Form 4 IONIS PHARMACEUTICALS For: Jun 10 Filed by: HERMAN JOAN E
Jun 14, 2021 04:05 PM Ionis' Chief Scientific Officer C. Frank Bennett, Ph.D., receives Gabbay Award in Biotechnology and Medicine

Back to IONS Stock Lookup